Emergent BioSolutions

Syngene to pay $37M for Emergent's Baltimore biologics plant

Syngene is paying $36.5 million for Emergent BioSolutions' Bayview plant in Baltimore, which the Indian CRDMO will use to beef up antibody production.

Fraiser Kansteiner Mar 10, 2025 3:45pm

JPM25: Recovering Emergent inks deal for opioid overdose spray

Jan 15, 2025 7:41pm

NIH study shows mpox shot elicits immune response in teens

Oct 17, 2024 11:17am

Emergent BioSolutions' mpox preparedness orders reach $400M

Sep 25, 2024 1:06pm

Emergent's smallpox vaccine wins FDA approval for mpox

Aug 30, 2024 11:23am

Emergent pledges smallpox vax doses to help fight mpox in Africa

Aug 20, 2024 10:25am